ASH Research Collaborative Data Hub

Enrolling by invitation

Conditions studied: Sickle Cell Disease, Multiple Myeloma

In brief

Benign and malignant hematologic diseases are relatively rare conditions within the spectrum of medical practice in any one site of care. Nonetheless, recent research in hematologic conditions from basic, translational, clinical and population perspectives offer the possibility of improving the way that these diseases are treated, and the outcomes experienced by patients. A repository that aggregates and validates this data across institutions and other practice settings is needed in order to identify variation in care, new findings, and further research.

Key facts

Study ID

NCT05775224

Run by

ASH Research Collaborative

People needed

100000

Starts

2020-04-29

Expected to finish

2099-04-29

Last updated by the study team

2024-06-17

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• ASH Research Collaborative — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.